[
  {
    "title": "Securities registered pursuant to Section 12(b) of the Act",
    "subtitle": "As of July 24, 2023, the number of outstanding shares of the registrant s common stock, par value $0.001 per share, was 30,577,519.",
    "markdown": "| Title of each class | Trading Symbol | Name of each exchange on which registered |\n| --- | --- | --- |\n| Common Stock, Par Value $0.001 Per Share | IRTC | The Nasdaq Stock Market LLC |",
    "footnotes": [],
    "units": "",
    "page": 1,
    "bbox": [
      22.5,
      32.6,
      547.6,
      80.0
    ],
    "som_region": [
      0.03676470588235294,
      0.8989279390585543,
      0.8947820725783803,
      0.9588588367808949
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 93.44,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC. TABLE OF CONTENTS",
    "subtitle": "",
    "markdown": "| Item | Page No |\n| --- | --- |\n| PART I. FINANCIAL INFORMATION | 1 |\n| Item 1. Financial Statements (Unaudited): | 1 |\n| Condensed Consolidated Balance Sheets | 1 |\n| Condensed Consolidated Statements of Operations | 2 |\n| Condensed Consolidated Statements of Comprehensive Loss | 3 |\n| Condensed Consolidated Statements of Cash Flows | 4 |\n| Condensed Consolidated Statements of Stockholders Equity | 5 |\n| Notes to Condensed Consolidated Financial Statements | 6 |\n| Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations | 24 |\n| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 30 |\n| Item 4. Controls and Procedures | 31 |\n| PART II. OTHER INFORMATION | 32 |\n| Item 1. Legal Proceedings | 32 |\n| Item 1A. Risk Factors | 32 |\n| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 62 |\n| Item 3. Defaults Upon Senior Securities | 62 |\n| Item 4. Mine Safety Disclosures | 62 |\n| Item 5. Other Information | 62 |\n| Item 6. Exhibits | 63 |\n| Exhibit Index | 63 |\n| Signatures | 64 |",
    "footnotes": [],
    "units": "",
    "page": 3,
    "bbox": [
      23.9,
      391.6,
      581.6,
      726.7
    ],
    "som_region": [
      0.039062403385935265,
      0.08249923436328618,
      0.95025634765625,
      0.5055520028779001
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 100.0,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC. Condensed Consolidated Balance Sheets",
    "subtitle": "(unaudited)",
    "markdown": "| | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| Assets |  |  |\n| Current assets: |  |  |\n| Cash and cash equivalents | $ 61,578 | $ 78,832 |\n| Marketable securities | 103,161 | 134,312 |\n| Accounts receivable, net | 51,108 | 49,918 |\n| Inventory | 14,478 | 15,155 |\n| Prepaid expenses and other current assets | 11,816 | 10,555 |\n| Total current assets | 242,141 | 288,772 |\n| Property and equipment, net | 89,845 | 75,670 |\n| Operating lease right-of-use assets | 57,917 | 60,666 |\n| Goodwill | 862 | 862 |\n| Other assets | 38,723 | 22,252 |\n| Total assets | $ 429,488 | $ 448,222 |\n| Liabilities and Stockholders Equity |  |  |\n| Current liabilities: |  |  |\n| Accounts payable | $ 7,150 | $ 7,517 |\n| Accrued liabilities | 64,469 | 65,497 |\n| Deferred revenue | 3,695 | 3,051 |\n| Operating lease liabilities, current portion | 14,099 | 13,031 |\n| Total current liabilities | 89,413 | 89,096 |\n| Debt, noncurrent portion | 34,942 | 34,935 |\n| Other noncurrent liabilities | 1,012 | 1,307 |\n| Operating lease liabilities, noncurrent portion | 80,242 | 83,072 |\n| Total liabilities | 205,609 | 208,410 |\n| Commitments and contingencies (Note 8) |  |  |\n| Stockholders equity: |  |  |\n| Preferred stock, $0.001 par value - 5,000 shares authorized; none issued and outstanding at June 30, 2023 and December 31, 2022 |  |  |\n| Common stock, $0.001 par value - 100,000 shares authorized; 30,550 shares at June 30, 2023 and 30,193 at December 31, 2022 issued and outstanding | 30 | 28 |\n| Additional paid-in capital | 803,792 | 762,380 |\n| Accumulated other comprehensive loss | (152) | (396) |\n| Accumulated deficit | (579,791) | (522,200) |\n| Total stockholders equity | 223,879 | 239,812 |\n| Total liabilities and stockholders equity | $ 429,488 | $ 448,222 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 7,
    "bbox": [
      25.9,
      168.1,
      585.5,
      696.7
    ],
    "som_region": [
      0.04237491632598678,
      0.12037632682106714,
      0.9567381416270935,
      0.7877368349017518
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 97.81,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC. Condensed Consolidated Statements of Operations",
    "subtitle": "",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| (unaudited) | | | | |\n| Revenue, net | $ 124,130 | $ 102,051 | $ 235,566 | $ 194,429 |\n| Cost of revenue | 37,905 | 31,806 | 73,660 | 62,425 |\n| Gross profit | 86,225 | 70,245 | 161,906 | 132,004 |\n| Operating expenses: | | | | |\n| Research and development | 13,677 | 11,945 | 28,519 | 22,487 |\n| Selling, general and administrative | 91,420 | 81,751 | 191,763 | 154,909 |\n| Impairment and restructuring charges | | | | 26,608 |\n| Total operating expenses | 105,097 | 93,696 | 220,282 | 204,004 |\n| Loss from operations | (18,872) | (23,451) | (58,376) | (72,000) |\n| Interest expense | (832) | (482) | (1,782) | (2,511) |\n| Interest and other income, net | 1,435 | 69 | 2,867 | 85 |\n| Loss before income taxes | (18,269) | (23,864) | (57,291) | (74,426) |\n| Income tax provision | 213 | 33 | 300 | 80 |\n| Net loss | $ (18,482) | $ (23,897) | $ (57,591) | $ (74,506) |\n| Net loss per common share, basic and diluted | $ (0.61) | $ (0.80) | $ (1.89) | $ (2.51) |\n| Weighted-average shares, basic and diluted | 30,502 | 29,843 | 30,400 | 29,720 |",
    "footnotes": [],
    "units": "(in thousands, except per share data)",
    "page": 8,
    "bbox": [
      30.4,
      389.4,
      581.0,
      720.7
    ],
    "som_region": [
      0.049670107224408316,
      0.09007452955149642,
      0.9494037503510518,
      0.5083930660979916
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.5,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC.",
    "subtitle": "Condensed Consolidated Statements of Comprehensive Loss",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| (unaudited) | | | | |\n| Net loss | $ (18,482) | $ (23,897) | $ (57,591) | $ (74,506) |\n| Other comprehensive income (loss): | | | | |\n| Net change in unrealized gains (losses) from marketable securities | (39) | (230) | 288 | (522) |\n| Cumulative translation adjustment | (44) | | (44) | |\n| Comprehensive loss | $ (18,565) | $ (24,127) | $ (57,347) | $ (75,028) |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 9,
    "bbox": [
      30.8,
      515.3,
      580.6,
      726.7
    ],
    "som_region": [
      0.05032111772524765,
      0.08249938849246863,
      0.9487041398590685,
      0.3493089386911103
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 91.87,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC. Condensed Consolidated Statements of Cash Flows",
    "subtitle": "(unaudited)",
    "markdown": "| | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- |\n| Cash flows from operating activities |  |  |\n| Net loss | $ (57,591) | $ (74,506) |\n| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |\n| Depreciation and amortization | 7,367 | 6,494 |\n| Stock-based compensation | 32,350 | 29,001 |\n| Amortization of premium and accretion of discounts, net | (2,211) | 363 |\n| Provision for doubtful accounts and contractual allowances | 37,486 | 29,249 |\n| Amortization of operating lease right-of-use assets | 2,749 | 7,863 |\n| Impairment charges |  | 23,164 |\n| Other | 141 | 227 |\n| Changes in operating assets and liabilities: |  |  |\n| Accounts receivable | (38,676) | (40,199) |\n| Inventory | 545 | (4,346) |\n| Prepaid expenses and other current assets | (1,260) | 1,167 |\n| Other assets | (13,471) | (4,090) |\n| Accounts payable | (367) | (4,522) |\n| Accrued liabilities | (1,270) | (1,276) |\n| Deferred revenue | 644 | (73) |\n| Operating lease liabilities | (1,761) | (7,773) |\n| Net cash used in operating activities | (35,325) | (39,257) |\n| Cash flows from investing activities |  |  |\n| Purchases of property and equipment | (17,820) | (16,404) |\n| Purchases of marketable securities | (72,851) | (91,519) |\n| Sales of marketable securities |  | 34,965 |\n| Maturities of marketable securities | 106,500 | 64,000 |\n| Purchase of strategic investment | (3,000) |  |\n| Net cash provided by (used in) investing activities | 12,829 | (8,958) |\n| Cash flows from financing activities |  |  |\n| Payment of loans |  | (21,389) |\n| Proceeds from term loan |  | 35,000 |\n| Proceeds from issuance of common stock in connection with employee equity incentive plans | 5,286 | 8,372 |\n| Payments of issuance costs for long-term debt |  | (77) |\n| Net cash provided by financing activities | 5,286 | 21,906 |\n| Effect of exchange rate changes | (44) |  |\n| Net decrease in cash and cash equivalents | (17,254) | (26,309) |\n| Cash and cash equivalents, beginning of period | 78,832 | 127,562 |\n| Cash and cash equivalents, end of period | $ 61,578 | $ 101,253 |\n| Supplemental disclosures of cash flow information: |  |  |\n| Interest paid | $ 1,417 | $ 2,214 |\n| Cash taxes paid | $ 288 | $ |\n| Cash received from tenant improvement allowances | $ 1,603 | $ |\n| Non-cash investing and financing activities: |  |  |\n| Property and equipment included in accounts payable and accrued liabilities | $ 107 | $ |\n| Right-of-use assets obtained in exchange for operating lease liabilities | $ | $ 7,666 |\n| Capitalized stock-based compensation in property and equipment | $ 3,776 | $ 2,782 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 10,
    "bbox": [
      24.7,
      65.6,
      586.7,
      720.7
    ],
    "som_region": [
      0.04038357890509312,
      0.09007452955149642,
      0.9586782019122753,
      0.9171943279227825
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 99.57,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "IRHYTHM TECHNOLOGIES, INC.",
    "subtitle": "Condensed Consolidated Statement of Stockholders Equity",
    "markdown": "| | Common Stock | | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total Stockholders' Equity |\n| --- | --- | --- | --- | --- | --- | --- |\n| | Shares | Amount | | | | |\n| (unaudited) | | | | | | |\n| Balance at December 31, 2021 | 29,494 | $ 27 | $ 685,594 | $ (406,045) | $ (61) | $ 279,515 |\n| Issuance of common stock in connection with employee equity incentive plans, net | 275 | | 1,076 | | | 1,076 |\n| Stock-based compensation | | | 15,152 | | | 15,152 |\n| Net loss | | | | (50,609) | | (50,609) |\n| Net change in unrealized loss on marketable securities | | | | | (292) | (292) |\n| Balance at March 31, 2022 | 29,769 | $ 27 | $ 701,822 | $ (456,654) | $ (353) | $ 244,842 |\n| Issuance of common stock in connection with employee equity incentive plans, net | 195 | 1 | 7,295 | | | 7,296 |\n| Stock-based compensation | | | 16,631 | | | 16,631 |\n| Net loss | | | | (23,897) | | (23,897) |\n| Net change in unrealized loss on marketable securities | | | | | (230) | (230) |\n| Balance at June 30, 2022 | 29,964 | $ 28 | $ 725,748 | $ (480,551) | $ (583) | $ 244,642 |\n| | | | | | | |\n| | Common Stock | | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Total Stockholders' Equity |\n| | Shares | Amount | | | | |\n| (unaudited) | | | | | | |\n| Balance at December 31, 2022 | 30,193 | $ 28 | $ 762,380 | $ (522,200) | $ (396) | $ 239,812 |\n| Issuance of common stock in connection with employee equity incentive plans, net | 270 | 2 | 903 | | | 905 |\n| Stock-based compensation | | | 19,899 | | | 19,899 |\n| Net loss | | | | (39,109) | | (39,109) |\n| Net change in unrealized gain on marketable securities | | | | | 327 | 327 |\n| Balance at March 31, 2023 | 30,463 | $ 30 | $ 783,182 | $ (561,309) | $ (69) | $ 221,834 |\n| Issuance of common stock in connection with employee equity incentive plans, net | 87 | | 4,383 | | | 4,383 |\n| Stock-based compensation | | | 16,227 | | | 16,227 |\n| Net loss | | | | (18,482) | | (18,482) |\n| Net change in unrealized loss on marketable securities | | | | | (39) | (39) |\n| Cumulative translation adjustment | | | | | (44) | (44) |\n| Balance at June 30, 2023 | 30,550 | $ 30 | $ 803,792 | $ (579,791) | $ (152) | $ 223,879 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 12,
    "bbox": [
      23.5,
      145.3,
      588.3,
      701.2
    ],
    "som_region": [
      0.03839224148419947,
      0.11469512515597874,
      0.9612296110664318,
      0.8165447350704309
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.07,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The following table presents the changes in the allowance for doubtful accounts (in thousands):",
    "subtitle": "",
    "markdown": "| | Six Months Ended June 30, 2023 | Year Ended December 31, 2022 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- |\n| Balance, beginning of period | $ 18,475 | $ 14,012 | $ 14,012 |\n| Add: provision for doubtful accounts | 9,424 | 17,191 | 7,623 |\n| Less: write-offs, net of recoveries and other adjustments | (8,489) | (12,728) | (7) |\n| Balance, end of period | $ 19,410 | $ 18,475 | $ 21,628 |",
    "footnotes": [],
    "units": "",
    "page": 15,
    "bbox": [
      23.5,
      322.6,
      587.9,
      425.6
    ],
    "som_region": [
      0.03839224148419947,
      0.4625772803720802,
      0.9606602488000409,
      0.592669053511186
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 97.73,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The following table presents the changes in the contractual allowance",
    "subtitle": "",
    "markdown": "| | Six Months Ended June 30, 2023 | Year Ended December 31, 2022 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- |\n| Balance, beginning of period | $ 41,389 | $ 31,274 | $ 31,274 |\n| Add: provision for contractual adjustments | 28,062 | 41,158 | 21,626 |\n| Less: contractual adjustments | (21,537) | (31,043) | (38) |\n| Balance, end of period | $ 47,914 | $ 41,389 | $ 52,862 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 15,
    "bbox": [
      23.5,
      236.4,
      585.5,
      319.9
    ],
    "som_region": [
      0.03839224148419947,
      0.5960950755109691,
      0.9566502789266748,
      0.7015669080946181
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 100.0,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Disaggregated Revenue by Payor Type",
    "subtitle": "For the three and six months ended June 30, 2023 and 2022",
    "markdown": "| | Three Months Ended June 30, 2023 | | Three Months Ended June 30, 2022 | | Six Months Ended June 30, 2023 | | Six Months Ended June 30, 2022 | |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| | Amount | % of Revenue | Amount | % of Revenue | Amount | % of Revenue | Amount | % of Revenue |\n| Contracted third-party payors | $ 67,324 | 54% | $ 55,451 | 54% | $ 129,231 | 55% | $ 107,202 | 55% |\n| Centers for Medicare and Medicaid | 30,871 | 25% | 24,759 | 24% | 57,362 | 24% | 44,821 | 23% |\n| Healthcare institutions | 18,214 | 15% | 15,671 | 16% | 33,995 | 15% | 30,749 | 16% |\n| Non-contracted third-party payors | 7,721 | 6% | 6,170 | 6% | 14,978 | 6% | 11,657 | 6% |\n| Total | $ 124,130 | | $ 102,051 | | $ 235,566 | | $ 194,429 | |",
    "footnotes": [],
    "units": "(in thousands, except percentages)",
    "page": 20,
    "bbox": [
      23.5,
      506.3,
      582.4,
      629.0
    ],
    "som_region": [
      0.03839224148419947,
      0.20577459624319366,
      0.9515783771190768,
      0.3606713420212871
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 97.95,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The fair value of cash equivalents and marketable securities as of June 30, 2023 and December 31, 2022, were as follows",
    "subtitle": "",
    "markdown": "| | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |\n| --- | --- | --- | --- | --- |\n| Money market funds | $ 23,562 | $ | $ | $ 23,562 |\n| U.S. government securities | 108,217 | 4 | (113) | 108,108 |\n| Total cash equivalents and marketable securities | $ 131,779 | $ 4 | $ (113) | $ 131,670 |\n| Classified as: | | | | |\n| Cash equivalents | | | | $ 28,509 |\n| Marketable securities | | | | 103,161 |\n| Total cash equivalents and marketable securities | | | | $ 131,670 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 21,
    "bbox": [
      23.5,
      510.8,
      587.1,
      644.0
    ],
    "som_region": [
      0.03839224148419947,
      0.18683643533725933,
      0.9593030144186581,
      0.3549895238394689
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.7,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Marketable securities",
    "subtitle": "December 31, 2022",
    "markdown": "|  | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |\n| --- | --- | --- | --- | --- |\n| Money market funds | $ 24,263 | $ | $ | $ 24,263 |\n| U.S. government securities | 134,709 | 12 | (409) | 134,312 |\n| Total cash equivalents and marketable securities | $ 158,972 | $ 12 | $ (409) | $ 158,575 |\n| Classified as: |  |  |  |  |\n| Cash equivalents | $ 24,263 |  |  |  |\n| Marketable securities | 134,312 |  |  |  |\n| Total cash equivalents and marketable securities | $ 158,575 |  |  |  |",
    "footnotes": [],
    "units": "",
    "page": 21,
    "bbox": [
      23.5,
      357.9,
      587.1,
      506.0
    ],
    "som_region": [
      0.03839224148419947,
      0.361071461378926,
      0.9593030144186581,
      0.5481639438205295
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 94.44,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Fair Value of Financial Assets",
    "subtitle": "June 30, 2023",
    "markdown": "| Assets | Level 1 | Level 2 | Level 3 | Total |\n| --- | --- | --- | --- | --- |\n| Money market funds | $ 23,562 | $ | $ | $ 23,562 |\n| U.S. government securities | | 108,108 | | 108,108 |\n| Total | $ 23,562 | $ 108,108 | $ | $ 131,670 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 23,
    "bbox": [
      23.5,
      474.8,
      587.1,
      563.0
    ],
    "som_region": [
      0.03839224148419947,
      0.2891054635096078,
      0.9592838661343444,
      0.4004440692940144
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.73,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Fair Value Measurements",
    "subtitle": "December 31, 2022",
    "markdown": "| Assets | Level 1 | Level 2 | Level 3 | Total |\n| --- | --- | --- | --- | --- |\n| Money market funds | $ 24,263 | $ | $ | $ 24,263 |\n| U.S. government securities | | 134,312 | | 134,312 |\n| Total | $ 24,263 | $ 134,312 | $ | $ 158,575 |",
    "footnotes": [],
    "units": "",
    "page": 23,
    "bbox": [
      23.5,
      362.4,
      586.3,
      449.8
    ],
    "som_region": [
      0.03839224148419947,
      0.43209295561819366,
      0.9580200793696384,
      0.5424821256387113
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.38,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Inventory",
    "subtitle": "",
    "markdown": "|  | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| Raw materials and work-in-process | $ 7,208 | $ 9,338 |\n| Finished goods | 7,270 | 5,817 |\n| Total | $ 14,478 | $ 15,155 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 23,
    "bbox": [
      23.5,
      226.6,
      587.9,
      289.3
    ],
    "som_region": [
      0.03839224148419947,
      0.6347346065020321,
      0.9606219522314133,
      0.7138762811217645
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.86,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Other Assets",
    "subtitle": "Other assets consisted of the following (in thousands):",
    "markdown": "| | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| PCBAs | $ 30,153 | $ 18,599 |\n| Cloud computing arrangements | 4,443 | 2,523 |\n| Strategic investment | 3,000 | |\n| Other | 1,127 | 1,130 |\n| Total | $ 38,723 | $ 22,252 |",
    "footnotes": [],
    "units": "",
    "page": 23,
    "bbox": [
      23.5,
      95.4,
      587.9,
      183.5
    ],
    "som_region": [
      0.03839224148419947,
      0.7682524401732166,
      0.9606219522314133,
      0.8795885798907039
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 100.0,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Property and Equipment, Net",
    "subtitle": "Property and equipment, net consisted of the following (in thousands):",
    "markdown": "| | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| Laboratory and manufacturing equipment | $ 5,655 | $ 4,911 |\n| Computer equipment and software | 2,448 | 2,315 |\n| Furniture and fixtures | 4,198 | 4,119 |\n| Leasehold improvements | 23,533 | 23,144 |\n| Internal-use software | 49,351 | 44,877 |\n| Internal-use software in development | 40,345 | 28,069 |\n| Construction in progress | 6,626 | 3,451 |\n| Total property and equipment, gross | 132,156 | 110,886 |\n| Less: accumulated depreciation and amortization | (42,311) | (35,216) |\n| Total property and equipment, net | $ 89,845 | $ 75,670 |",
    "footnotes": [],
    "units": "",
    "page": 25,
    "bbox": [
      23.5,
      486.8,
      587.9,
      641.0
    ],
    "som_region": [
      0.03839224148419947,
      0.1906243141251381,
      0.9606307285283905,
      0.38529132110903963
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 98.57,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Accrued Liabilities",
    "subtitle": "Accrued liabilities consisted of the following (in thousands):",
    "markdown": "| | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| Accrued payroll and related expenses | $ 27,159 | $ 34,752 |\n| Accrued vacation | 10,041 | 8,608 |\n| Accrued expenses | 10,255 | 7,006 |\n| Claims payable | 7,257 | 4,464 |\n| Accrued employee share purchase plan contributions | 1,090 | 1,045 |\n| Accrued income and sales taxes | 2,604 | 2,388 |\n| Accrued professional services fees | 6,063 | 7,234 |\n| Total accrued liabilities | $ 64,469 | $ 65,497 |",
    "footnotes": [
      "During the year ended December 31, 2022 and the six months ended June 30, 2023, the Company has incurred expenses in connection with efforts to further globalize its operational footprint and expects to continue to incur such expenses through mid-2024."
    ],
    "units": "",
    "page": 25,
    "bbox": [
      23.5,
      181.6,
      587.9,
      335.0
    ],
    "som_region": [
      0.03839224148419947,
      0.5769706880203401,
      0.9606219522314133,
      0.7706907638395676
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 94.13,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Restructuring charges, Impairment charges, and Total for Six Months Ended June 30, 2022",
    "subtitle": "",
    "markdown": "| | Six Months Ended June 30, 2022 |\n| --- | --- |\n| Restructuring charges | $ 3,444 |\n| Impairment charges | 23,164 |\n| Total | $ 26,608 |",
    "footnotes": [
      "The Company did not record any impairment charges during the three months ended June 30, 2022."
    ],
    "units": "(in thousands)",
    "page": 26,
    "bbox": [
      23.5,
      495.1,
      578.2,
      593.0
    ],
    "som_region": [
      0.03839224148419947,
      0.2512279086642795,
      0.9447870192184946,
      0.37487465444237295
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 93.73,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The following table provides a summary of changes in the restructuring liabilities associated with the Restructuring Plan",
    "subtitle": "",
    "markdown": "| | December 31, 2022 | Charges | Cash Payments | June 30, 2023 |\n| --- | --- | --- | --- | --- |\n| Employee severance | $ 394 | $ | $ (394) | $ |\n| Total | $ 394 | $ | $ (394) | $ |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 26,
    "bbox": [
      23.5,
      363.1,
      564.0,
      413.8
    ],
    "som_region": [
      0.03839224148419947,
      0.47754380197236035,
      0.9216470157398897,
      0.5415363889752012
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.66,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Contractual obligations under operating lease liabilities were as follows",
    "subtitle": "",
    "markdown": "| Year Ending December 31: | |\n| --- | --- |\n| 2023 (remainder of the year) | $ 10,417 |\n| 2024 | 20,592 |\n| 2025 | 20,385 |\n| 2026 | 20,136 |\n| 2027 | 19,736 |\n| Thereafter | 36,124 |\n| Total lease payments | 127,390 |\n| Less: imputed interest | (33,049) |\n| Total lease liabilities | $ 94,341 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 27,
    "bbox": [
      22.5,
      515.3,
      584.7,
      683.2
    ],
    "som_region": [
      0.03676470588235294,
      0.13742116484979186,
      0.955396963879953,
      0.3493089386911103
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 100.0,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Future minimum payments",
    "subtitle": "Contractual obligations for the 2022 Term Loans comprise principal and interest payments as follows (in thousands):",
    "markdown": "| Year Ending December 31, |  |\n| --- | --- |\n| 2023 (remainder of the year) | $ 1,512 |\n| 2024 | 3,025 |\n| 2025 | 15,763 |\n| 2026 | 18,693 |\n| 2027 | 4,438 |\n| Total | 43,431 |\n| Less: Amount representing interest | (8,431) |\n| Less: Debt issuance costs | (58) |\n| Principal payments | $ 34,942 |",
    "footnotes": [],
    "units": "",
    "page": 29,
    "bbox": [
      23.5,
      168.1,
      584.7,
      311.2
    ],
    "som_region": [
      0.03839224148419947,
      0.6070983963783342,
      0.9553946700750613,
      0.7877386844519413
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 100.0,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The Company had reserved shares of common stock for issuance as follows",
    "subtitle": "",
    "markdown": "| | June 30, 2023 | December 31, 2022 |\n| --- | --- | --- |\n| Options issued and outstanding | 309 | 328 |\n| Unvested RSUs and PRSUs 1 | 2,517 | 2,026 |\n| Shares available for grant under future stock plans | 7,039 | 7,823 |\n| Shares available for future issuance | 9,865 | 10,177 |",
    "footnotes": [
      "PRSUs are based on the maximum number of PRSUs in the key executive grant agreements. The actual number of PRSUs granted will be based on the annual unit volume compound annual growth rate ( CAGR ) discussed in Note 12, Equity Incentive Plan and Stock-Based Compensation."
    ],
    "units": "(in thousands)",
    "page": 31,
    "bbox": [
      22.5,
      469.5,
      587.8,
      573.5
    ],
    "som_region": [
      0.03676470588235294,
      0.27584665471857245,
      0.9605293024599162,
      0.40719681556778725
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 94.88,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "A summary of awards available for grant under the Company s 2016 Equity Incentive Plan is as follows",
    "subtitle": "",
    "markdown": "| | Shares Available for Grant |\n| --- | --- |\n| Balance as of December 31, 2022 | 7,823 |\n| Awards granted 1 | (938) |\n| Awards forfeited 1 | 154 |\n| Balance as of June 30, 2023 | 7,039 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 31,
    "bbox": [
      23.5,
      358.6,
      586.3,
      448.4
    ],
    "som_region": [
      0.03839224148419947,
      0.433807873966718,
      0.9579252355238971,
      0.5472157410901002
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.88,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Performance Based Restricted Stock Units and Market-Based Units",
    "subtitle": "",
    "markdown": "| | Shares Underlying RSUs | Weighted Average Grant Date Fair Value | Shares Underlying PRSUs 1 | Weighted Average Grant Date Fair Value |\n| --- | --- | --- | --- | --- |\n| Balance as of December 31, 2022 | 1,465 | $ 111.16 | 561 | $ 120.22 |\n| Granted | 670 | 118.32 | 268 | 135.95 |\n| Vested | (268) | 124.69 | (24) | 107.05 |\n| Forfeited | (91) | 114.97 | (64) | 119.29 |\n| Balance as of June 30, 2023 | 1,776 | $ 111.63 | 741 | $ 126.42 |",
    "footnotes": [
      "1"
    ],
    "units": "(in thousands, except weighted average grant date fair value)",
    "page": 32,
    "bbox": [
      23.5,
      511.6,
      587.1,
      641.0
    ],
    "som_region": [
      0.03839224148419947,
      0.1906243141251381,
      0.9592606288934844,
      0.35404132110903963
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 90.02,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Options Outstanding",
    "subtitle": "For the six months ended June 30, 2023",
    "markdown": "| | Options Outstanding | Weighted-Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life (years) | Aggregate Intrinsic Value |\n| --- | --- | --- | --- | --- |\n| Balance as of December 31, 2022 | 328 | $ 43.00 | 4.43 | $ 16,635 |\n| Options exercised | (19) | 54.14 | | |\n| Balance as of June 30, 2023 | 309 | 42.31 | 3.91 | 19,161 |\n| Options exercisable June 30, 2023 | 309 | $ 42.31 | 3.91 | $ 19,161 |",
    "footnotes": [
      "There have been no options granted since December 31, 2019. As of June 30, 2023, the options were fully vested."
    ],
    "units": "(in thousands, except weighted average exercise price per share and years)",
    "page": 33,
    "bbox": [
      23.5,
      499.6,
      587.0,
      653.0
    ],
    "som_region": [
      0.03839224148419947,
      0.17547526504054214,
      0.959158305249183,
      0.36919530232747394
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.19,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Stock-Based Compensation Expense",
    "subtitle": "For the three and six months ended June 30, 2023 and 2022",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| Cost of revenue | $ 784 | $ 536 | $ 1,348 | $ 922 |\n| Research and development | 2,155 | 1,629 | 4,542 | 3,124 |\n| Selling, general and administrative | 11,160 | 12,933 | 26,460 | 24,955 |\n| Total stock-based compensation expense | $ 14,099 | $ 15,098 | $ 32,350 | $ 29,001 |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 33,
    "bbox": [
      23.5,
      168.1,
      587.1,
      256.3
    ],
    "som_region": [
      0.03839224148419947,
      0.6764025447344539,
      0.9593039119944853,
      0.7877386844519413
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.86,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Net Loss Per Share Computation - Three and Six Months Ended June 30, 2023 and 2022",
    "subtitle": "",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| Numerator: | | | | |\n| Net loss | $ (18,482) | $ (23,897) | $ (57,591) | $ (74,506) |\n| Denominator: | | | | |\n| Weighted-average shares used to compute net loss per common share, basic and diluted | 30,502 | 29,843 | 30,400 | 29,720 |\n| Net loss per common share, basic and diluted | $ (0.61) | $ (0.80) | $ (1.89) | $ (2.51) |",
    "footnotes": [],
    "units": "(in thousands, except per share data)",
    "page": 34,
    "bbox": [
      23.5,
      534.1,
      587.9,
      647.0
    ],
    "som_region": [
      0.03839224148419947,
      0.18304855654938054,
      0.9606713189019097,
      0.3256347155330157
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.74,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the six months ended June 30, 2023 and 2022 because their inclusion would be anti-dilutive",
    "subtitle": "",
    "markdown": "| | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- |\n| Options to purchase common stock | 309 | 381 |\n| RSUs and PRSUs 1 unvested | 2,518 | 2,017 |\n| Total | 2,827 | 2,398 |",
    "footnotes": [
      "1"
    ],
    "units": "(in thousands)",
    "page": 34,
    "bbox": [
      23.5,
      423.1,
      587.9,
      498.5
    ],
    "som_region": [
      0.03839224148419947,
      0.37054115834862295,
      0.9606633404501123,
      0.46578127928454466
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.87,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Zio Services Revenue by Payor Type",
    "subtitle": "Shown as a percentage of revenue",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| Contracted third-party payors | 54% | 54% | 55% | 55% |\n| Centers for Medicare and Medicaid | 25% | 24% | 24% | 23% |\n| Healthcare institutions | 15% | 16% | 15% | 16% |\n| Non-contracted third-party payors | 6% | 6% | 6% | 6% |",
    "footnotes": [],
    "units": "",
    "page": 35,
    "bbox": [
      22.5,
      253.4,
      564.4,
      365.0
    ],
    "som_region": [
      0.03676470588235294,
      0.5390943662084714,
      0.9222979576759088,
      0.6800590283942946
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 96.3,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Reconciliation of Net Loss to Adjusted EBITDA",
    "subtitle": "",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- | --- | --- |\n| Net loss | $ (18,482) | $ (23,897) | $ (57,591) | $ (74,506) |\n| Interest expense | 832 | 482 | 1,782 | 2,511 |\n| Interest income | (1,468) | (196) | (2,902) | (328) |\n| Income tax provision | 213 | 33 | 300 | 80 |\n| Depreciation and amortization | 3,791 | 3,351 | 7,367 | 6,494 |\n| Stock-based compensation | 14,099 | 15,098 | 32,350 | 29,001 |\n| Impairment and restructuring charges | | | | 26,608 |\n| Business transformation costs | 5,409 | 175 | 11,095 | 433 |\n| Adjusted EBITDA | $ 4,394 | $ (4,954) | $ (7,599) | $ (9,707) |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 36,
    "bbox": [
      23.5,
      443.3,
      587.9,
      598.3
    ],
    "som_region": [
      0.03839224148419947,
      0.24460158685241085,
      0.9606476827384599,
      0.440215563533282
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 97.73,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Results of Operations",
    "subtitle": "Comparison of the Three and Six Months Ended June 30, 2023 and 2022.",
    "markdown": "| | Three Months Ended June 30, 2023 | Three Months Ended June 30, 2022 | $ Change* | % Change | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 | $ Change* | % Change |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Revenue | $ 124,130 | $ 102,051 | $ 22,079 | 22% | $ 235,566 | $ 194,429 | $ 41,137 | 21% |\n| Cost of revenue | 37,905 | 31,806 | 6,099 | 19% | 73,660 | 62,425 | 11,235 | 18% |\n| Gross profit | 86,225 | 70,245 | 15,980 | 23% | 161,906 | 132,004 | 29,902 | 23% |\n| Operating expenses: | | | | | | | | |\n| Research and development | 13,677 | 11,945 | 1,732 | 14% | 28,519 | 22,487 | 6,032 | 27% |\n| Selling, general and administrative | 91,420 | 81,751 | 9,669 | 12% | 191,763 | 154,909 | 36,854 | 24% |\n| Impairment and restructuring charges | | | % | | | 26,608 | (26,608) | (100)% |\n| Total operating expenses | 105,097 | 93,696 | 11,401 | 12% | 220,282 | 204,004 | 16,278 | 8% |\n| Loss from operations | (18,872) | (23,451) | 4,579 | (20)% | (58,376) | (72,000) | 13,624 | (19)% |\n| Interest expense | (832) | (482) | (350) | 73% | (1,782) | (2,511) | 729 | (29)% |\n| Interest and other income, net | 1,435 | 69 | 1,366 | nm | 2,867 | 85 | 2,782 | nm |\n| Loss before income taxes | (18,269) | (23,864) | 5,595 | (23)% | (57,291) | (74,426) | 17,135 | (23)% |\n| Income tax provision | 213 | 33 | 180 | 545% | 300 | 80 | 220 | 275% |\n| Net loss | $ (18,482) | $ (23,897) | $ 5,415 | (23)% | $ (57,591) | $ (74,506) | $ 16,915 | (23)% |",
    "footnotes": [],
    "units": "(dollars in thousands, except percentages)",
    "page": 39,
    "bbox": [
      23.5,
      401.0,
      584.5,
      640.4
    ],
    "som_region": [
      0.03839224148419947,
      0.19139598114321932,
      0.9550791223064746,
      0.49364101525508997
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 97.54,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "Cash Flows Summary",
    "subtitle": "",
    "markdown": "| | Six Months Ended June 30, 2023 | Six Months Ended June 30, 2022 |\n| --- | --- | --- |\n| Net cash (used in) provided by: | | |\n| Operating activities | $ (35,325) | $ (39,257) |\n| Investing activities | 12,829 | (8,958) |\n| Financing activities | 5,286 | 21,906 |\n| Net decrease in cash and cash equivalents | $ (17,210) | $ (26,309) |",
    "footnotes": [],
    "units": "(in thousands)",
    "page": 43,
    "bbox": [
      22.5,
      555.1,
      587.9,
      681.4
    ],
    "som_region": [
      0.03676470588235294,
      0.13967663350731435,
      0.9607020359413296,
      0.29912449615170256
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 95.13,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  },
  {
    "title": "EXHIBIT INDEX",
    "subtitle": "",
    "markdown": "| Exhibit Number | Description | Form | Date | Number | Filed Herewith |\n| --- | --- | --- | --- | --- | --- |\n| 31.1 | Certification of Chief Executive Officer required by Securities Exchange Act Rules 13a-14(a) and 15d-14(a). |  |  |  | X |\n| 31.2 | Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) |  |  |  | X |\n| 32.1* | Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350. |  |  |  | X |\n| 101.INS | Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document |  |  |  | X |\n| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |  | X |\n| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | X |\n| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | X |\n| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | X |\n| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | X |\n| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  | X |",
    "footnotes": [
      "The certifications filed as Exhibits 32.1 are not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act ), or otherwise subject to the liability of that section, nor shall they be deemed and are not to be incorporated"
    ],
    "units": "",
    "page": 102,
    "bbox": [
      22.5,
      181.6,
      580.7,
      557.2
    ],
    "som_region": [
      0.03676470588235294,
      0.2965071514399365,
      0.948820326063368,
      0.7706932299064867
    ],
    "flavor": "stream",
    "kind": "text_table",
    "source": ".cache/s3/qubera-docs/daloopa/79045584/79045584.pdf",
    "camelot_accuracy": 85.66,
    "classifier_decision": null,
    "llm_corrected": true,
    "extraction_record": null
  }
]